Suppr超能文献

人脑肿瘤中端粒酶活性:星形细胞瘤和脑膜瘤。

Telomerase activity in human brain tumors: astrocytoma and meningioma.

机构信息

Pediatric Inherited Diseases Research Center, Genetics and Molecular Biology Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Cell Mol Neurobiol. 2013 May;33(4):569-74. doi: 10.1007/s10571-013-9923-x. Epub 2013 Mar 20.

Abstract

Somatic cells do not have telomerase activity but immortalized cell lines and more than 85 % of the cancer cells show telomerase activation to prevent the telomere from progressive shortening. The activation of this enzyme has been found in a variety of human tumors and tumor-derived cell lines, but only few studies on telomerase activity in human brain tumors have been reported. Here, we evaluated telomerase activity in different grades of human astrocytoma and meningioma brain tumors. In this study, assay for telomerase activity performed on 50 eligible cases consisted of 26 meningioma, 24 astrocytoma according to the standard protocols. In the brain tissues, telomerase activity was positive in 39 (65 %) of 50 patients. One sample t test showed that the telomerase activity in meningioma and astrocytoma tumors was significantly positive entirely (P < 0.001). Also, grade I of meningioma and low grades of astrocytoma (grades I and II) significantly showed telomerase activity. According to our results, we suggest that activation of telomerase is an event that starts mostly at low grades of brain including meningioma and astrocytoma tumors.

摘要

体细胞没有端粒酶活性,但永生化细胞系和超过 85%的癌细胞显示端粒酶激活,以防止端粒进行性缩短。这种酶的激活已在多种人类肿瘤和肿瘤衍生的细胞系中发现,但关于人类脑肿瘤中端粒酶活性的研究很少。在这里,我们评估了不同分级的人脑星形细胞瘤和脑膜瘤脑肿瘤中端粒酶的活性。在这项研究中,根据标准方案,对 50 例合格病例进行了端粒酶活性检测,其中包括 26 例脑膜瘤和 24 例星形细胞瘤。在脑组织中,50 例患者中有 39 例(65%)端粒酶活性阳性。单样本 t 检验显示脑膜瘤和星形细胞瘤肿瘤的端粒酶活性均显著阳性(P<0.001)。此外,I 级脑膜瘤和低级别星形细胞瘤(I 级和 II 级)显著显示端粒酶活性。根据我们的结果,我们认为端粒酶的激活是一个事件,主要发生在包括脑膜瘤和星形细胞瘤在内的脑的低级别。

相似文献

1
Telomerase activity in human brain tumors: astrocytoma and meningioma.
Cell Mol Neurobiol. 2013 May;33(4):569-74. doi: 10.1007/s10571-013-9923-x. Epub 2013 Mar 20.
2
Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Oncol Rep. 2007 Dec;18(6):1571-6. doi: 10.3892/or.18.6.1571.
4
Correlations between the expression of hTERT and α and β splice variants in human brain tumors.
Adv Clin Exp Med. 2019 Apr;28(4):507-513. doi: 10.17219/acem/81934.
6
Telomere length modulation in human astroglial brain tumors.
PLoS One. 2013 May 14;8(5):e64296. doi: 10.1371/journal.pone.0064296. Print 2013.
8
Correlation of clinical features and telomerase activity in human gliomas.
J Neurooncol. 1999 Jun;43(2):137-42. doi: 10.1023/a:1006258817785.
9
Alterations of telomere length in human brain tumors.
Med Oncol. 2011 Sep;28(3):864-70. doi: 10.1007/s12032-010-9506-3. Epub 2010 Apr 7.

引用本文的文献

1
The causal relationship between genetically determined telomere length and meningiomas risk.
Front Neurol. 2023 Aug 24;14:1178404. doi: 10.3389/fneur.2023.1178404. eCollection 2023.
2
TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.
Neuro Oncol. 2018 Nov 12;20(12):1584-1593. doi: 10.1093/neuonc/noy104.
3
The Emerging Roles for Telomerase in the Central Nervous System.
Front Mol Neurosci. 2018 May 16;11:160. doi: 10.3389/fnmol.2018.00160. eCollection 2018.
5
Comprehensive analysis of Iranian reports of pediatric central nervous system tumors.
Childs Nerv Syst. 2017 Sep;33(9):1481-1490. doi: 10.1007/s00381-017-3468-0. Epub 2017 May 29.
6
Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors.
Cell Mol Neurobiol. 2018 Mar;38(2):393-419. doi: 10.1007/s10571-017-0498-9. Epub 2017 May 10.
7
Vaccination strategies for neuro-oncology.
Neuro Oncol. 2015 Nov;17 Suppl 7(Suppl 7):vii15-vii25. doi: 10.1093/neuonc/nov159.
8
Oncolytic adenoviruses: A thorny path to glioma cure.
Genes Dis. 2014 Dec;1(2):214-226. doi: 10.1016/j.gendis.2014.09.009.
9
Brain tumors: Special characters for research and banking.
Adv Biomed Res. 2015 Jan 6;4:4. doi: 10.4103/2277-9175.148261. eCollection 2015.

本文引用的文献

2
Alterations of telomere length in human brain tumors.
Med Oncol. 2011 Sep;28(3):864-70. doi: 10.1007/s12032-010-9506-3. Epub 2010 Apr 7.
3
Telomere and telomerase in stem cells.
Br J Cancer. 2007 Apr 10;96(7):1020-4. doi: 10.1038/sj.bjc.6603671. Epub 2007 Mar 13.
5
Prognostic implication of telomerase activity in patients with brain tumors.
J Korean Med Sci. 2006 Feb;21(1):126-30. doi: 10.3346/jkms.2006.21.1.126.
7
Telomeres and human disease: ageing, cancer and beyond.
Nat Rev Genet. 2005 Aug;6(8):611-22. doi: 10.1038/nrg1656.
8
Telomerase in brain tumors.
Childs Nerv Syst. 2002 Apr;18(3-4):112-7. doi: 10.1007/s00381-002-0562-7. Epub 2002 Feb 23.
9
Clinical utility of telomerase in cancer.
Oncogene. 2002 Jan 21;21(4):643-9. doi: 10.1038/sj.onc.1205070.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验